Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient children
European Journal of Endocrinology, ISSN: 0804-4643, Vol: 154, Issue: 3, Page: 479-482
2006
- 14Citations
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes14
- 14
- CrossRef8
- Captures1
- Readers1
Article Description
Objective: The aim was to investigate the effects of two different GH dosage regimens on growth, bone geometry and bone strength. Subjects and methods: Final height; parentally adjusted final height; the metacarpal index (MI) SDS, the inner and outer diameters; and the total cross-sectional area (CSA), cortical CSA, medullary CSA and bone strength (Bending Breaking Resistance Index (BBRI)) were evaluated at the metacarpal site in two cohorts of GH-deficient children, treated with two different doses of GH. Group 1 (38 patients) was treated with 0.16 mg/kg body weight per week of GH and group 2 (37 patients) with 0.3 mg/kg per week. Results: At the end of treatment, with group 1 vs group 2, height SDS was -0.84±1.07 vs -0.46±0.76, and parentally adjusted height SDS was 0.14±1.08 vs 0.27±0.82. Parentally adjusted relative height gain was 1.14±0.89 vs 2.14±0.72 SDS (P < 0.0001). MI SDS was 0.58±1.31 vs -0.42±1.54 (P < 0.005). MI SDS gain was 0.07±1.41 vs -0.35±1.85. There was no difference between groups in the outer and inner diameter, in the total and cortical CSAs, whereas medullary CSA was higher in group 2 (P < 0.05). BBRI was 10.02±5.37 vs 11.52±5.49 cm, and BBRI gain was 3.33±5.06 vs 6.88±6.65 (P = 0.01). P values were assessed using student's t-test. Conclusion: Higher GH doses result in a greater height gain and improved bone strength. © 2006 Society of the European Journal of Endocrinology.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33645218777&origin=inward; http://dx.doi.org/10.1530/eje.1.02113; http://www.ncbi.nlm.nih.gov/pubmed/16498062; https://academic.oup.com/ejendo/article/154/3/479/6695601; http://www.eje-online.org/cgi/doi/10.1530/eje.1.02113; http://www.eje-online.org/content/154/3/479
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know